Loading…

Prediction of Liver Complications in Patients With Hepatitis C Virus–Related Cirrhosis With and Without HIV Coinfection: Comparison of Hepatic Venous Pressure Gradient and Transient Elastography

Background. Hepatic venous pressure gradient (HVPG) is the best indicator of prognosis in patients with compensated cirrhosis. We compared HVPG and transient elastography (TE) for the prediction of liver-related events (LREs) in patients with hepatitis C virus (HCV)–related cirrhosis with or without...

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases 2014-03, Vol.58 (5), p.713-718
Main Authors: Pérez-Latorre, Leire, Sánchez-Conde, Matilde, Rincón, Diego, Miralles, Pilar, Aldámiz-Echevarría, Teresa, Carrero, Ana, Tejerina, Francisco, Díez, Cristina, Bellón, José María, Bañares, Rafael, Berenguer, Juan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background. Hepatic venous pressure gradient (HVPG) is the best indicator of prognosis in patients with compensated cirrhosis. We compared HVPG and transient elastography (TE) for the prediction of liver-related events (LREs) in patients with hepatitis C virus (HCV)–related cirrhosis with or without human immunodeficiency virus (HIV) coinfection. Methods. This was a retrospective review of all consecutive patients with compensated HCV-related cirrhosis who were assessed simultaneously using TE and HVPG between January 2005 and December 2011. We used receiver operating characteristic (ROC) curves to determine the ability of TE and HVPG to predict the first LRE (liver decompensation or hepatocellular carcinoma). Results. The study included 60 patients, 36 of whom were coinfected with HIV. After a median follow-up of 42 months, 6 patients died, 8 experienced liver decompensations, and 7 were diagnosed with hepatocellular carcinoma. The area under the ROC curve (AUROC) of TE and HVPG for prediction of LREs in all patients was 0.85 (95% confidence interval [CI], .73–.97) and 0.76 (95% CI, .63–.89) (P = .13); for HIV-infected patients, the AUROC was 0.85 (95% CI, .67–1.00) and 0.81 (95% CI, .64–.97) (P = .57); and for non-HIV-infected patients, the AUROC was 0.88 (95% CI, .75–1.00) and 0.77 (95% CI, .57–.97) (P = .19). Based on the AUROC values, 2 TE cutoff points were chosen to predict the absence (
ISSN:1058-4838
1537-6591
DOI:10.1093/cid/cit768